Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

58.29 -0.32 (-0.55%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
August 14, 2006
Form 5
Source: SEC/Edgar
August 14, 2006
Form 4
Source: SEC/Edgar
August 10, 2006
Form 3
Source: SEC/Edgar
July 30, 2006
Form 3
Source: SEC/Edgar
July 30, 2006
Form 4
Source: SEC/Edgar
July 27, 2006
Form 4
Source: SEC/Edgar
July 23, 2006
Form 4
Source: SEC/Edgar
July 23, 2006
Form 4
Source: SEC/Edgar
May 07, 2006
Form 4
Source: SEC/Edgar
May 07, 2006
Form 4
Source: SEC/Edgar
May 07, 2006
Form 4
Source: SEC/Edgar
May 07, 2006
Form 4
Source: SEC/Edgar
May 07, 2006
Form 4
Source: SEC/Edgar
May 07, 2006
Form 3
Source: SEC/Edgar
April 27, 2006
Form 3
Source: SEC/Edgar
April 27, 2006
Form 3
Source: SEC/Edgar
April 10, 2006
Form 3
Source: SEC/Edgar
March 22, 2006
Form 3
Source: SEC/Edgar
March 22, 2006
Form 4
Source: SEC/Edgar
March 22, 2006
Form 4
Source: SEC/Edgar
January 18, 2006
Form 3
Source: SEC/Edgar
January 05, 2006
Form 4
Source: SEC/Edgar
January 05, 2006
Form 4
Source: SEC/Edgar
October 24, 2005
Form 4
Source: SEC/Edgar
October 24, 2005
Form 4
Source: SEC/Edgar
October 24, 2005
Form 4
Source: SEC/Edgar
October 24, 2005
Form 4
Source: SEC/Edgar
October 24, 2005
Form 4
Source: SEC/Edgar
October 24, 2005
Form 4
Source: SEC/Edgar
October 24, 2005
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.